These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34681207)

  • 1. Endothelial Thioredoxin-Interacting Protein Depletion Reduces Hemorrhagic Transformation in Hyperglycemic Mice after Embolic Stroke and Thrombolytic Therapy.
    Salman M; Ismael S; Li L; Ahmed HA; Puchowicz MA; Ishrat T
    Pharmaceuticals (Basel); 2021 Sep; 14(10):. PubMed ID: 34681207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute Hyperglycemia Exacerbates Hemorrhagic Transformation after Embolic Stroke and Reperfusion with tPA: A Possible Role of TXNIP-NLRP3 Inflammasome.
    Salman M; Ismael S; Li L; Ahmed HA; Puchowicz MA; Ishrat T
    J Stroke Cerebrovasc Dis; 2022 Feb; 31(2):106226. PubMed ID: 34847489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue Plasminogen Activator Promotes TXNIP-NLRP3 Inflammasome Activation after Hyperglycemic Stroke in Mice.
    Ismael S; Nasoohi S; Yoo A; Ahmed HA; Ishrat T
    Mol Neurobiol; 2020 Jun; 57(6):2495-2508. PubMed ID: 32172516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Verapamil as an Adjunct Therapy to Reduce tPA Toxicity in Hyperglycemic Stroke: Implication of TXNIP/NLRP3 Inflammasome.
    Ismael S; Nasoohi S; Yoo A; Mirzahosseini G; Ahmed HA; Ishrat T
    Mol Neurobiol; 2021 Aug; 58(8):3792-3804. PubMed ID: 33847912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thioredoxin-interacting protein: a novel target for neuroprotection in experimental thromboembolic stroke in mice.
    Ishrat T; Mohamed IN; Pillai B; Soliman S; Fouda AY; Ergul A; El-Remessy AB; Fagan SC
    Mol Neurobiol; 2015 Apr; 51(2):766-78. PubMed ID: 24939693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Analysis of Different Methods of Ischemia/Reperfusion in Hyperglycemic Stroke Outcomes: Interaction with tPA.
    Hafez S; Hoda MN; Guo X; Johnson MH; Fagan SC; Ergul A
    Transl Stroke Res; 2015 Jun; 6(3):171-80. PubMed ID: 25683354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candesartan reduces the hemorrhage associated with delayed tissue plasminogen activator treatment in rat embolic stroke.
    Ishrat T; Pillai B; Ergul A; Hafez S; Fagan SC
    Neurochem Res; 2013 Dec; 38(12):2668-77. PubMed ID: 24194350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of ML351 and tissue plasminogen activator combination therapy in a rat model of focal embolic stroke.
    Cheng G; Zhao W; Xin Y; Huang G; Liu Y; Li Z; Zhan M; Li Y; Lu L; van Leyen K; Liu Y
    J Neurochem; 2021 May; 157(3):586-598. PubMed ID: 33481248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient brain hypothermia reduces the reperfusion injury of delayed tissue plasminogen activator and extends its therapeutic time window in a focal embolic stroke model.
    Zarisfi M; Allahtavakoli F; Hassanipour M; Khaksari M; Rezazadeh H; Allahtavakoli M; Taghavi MM
    Brain Res Bull; 2017 Sep; 134():85-90. PubMed ID: 28710023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes Worsens Functional Outcomes in Young Female Rats: Comparison of Stroke Models, Tissue Plasminogen Activator Effects, and Sexes.
    Li W; Ward R; Valenzuela JP; Dong G; Fagan SC; Ergul A
    Transl Stroke Res; 2017 Mar; ():. PubMed ID: 28247188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of the neurovascular injury and functional outcomes in experimental stroke models in diabetic Goto-Kakizaki rats.
    Li W; Qu Z; Prakash R; Chung C; Ma H; Hoda MN; Fagan SC; Ergul A
    Brain Res; 2013 Dec; 1541():106-14. PubMed ID: 24144674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylated recombinant HSP27 protects the brain and attenuates blood-brain barrier disruption following stroke in mice receiving intravenous tissue-plasminogen activator.
    Shimada Y; Shimura H; Tanaka R; Yamashiro K; Koike M; Uchiyama Y; Urabe T; Hattori N
    PLoS One; 2018; 13(5):e0198039. PubMed ID: 29795667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix Metalloprotease 3 Exacerbates Hemorrhagic Transformation and Worsens Functional Outcomes in Hyperglycemic Stroke.
    Hafez S; Abdelsaid M; El-Shafey S; Johnson MH; Fagan SC; Ergul A
    Stroke; 2016 Mar; 47(3):843-51. PubMed ID: 26839355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinase-2 deletions protect against hemorrhagic transformation after 1 h of cerebral ischemia and 23 h of reperfusion.
    Lu A; Suofu Y; Guan F; Broderick JP; Wagner KR; Clark JF
    Neuroscience; 2013 Dec; 253():361-7. PubMed ID: 24035828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinase-2 or -9 deletions protect against hemorrhagic transformation during early stage of cerebral ischemia and reperfusion.
    Suofu Y; Clark JF; Broderick JP; Kurosawa Y; Wagner KR; Lu A
    Neuroscience; 2012 Jun; 212():180-9. PubMed ID: 22521821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vepoloxamer Enhances Fibrinolysis of tPA (Tissue-Type Plasminogen Activator) on Acute Ischemic Stroke.
    Wang C; Huang R; Li C; Lu M; Emanuele M; Zhang ZG; Chopp M; Zhang L
    Stroke; 2019 Dec; 50(12):3600-3608. PubMed ID: 31587657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxynitrite-Induced Tyrosine Nitration Contributes to Matrix Metalloprotease-3 Activation: Relevance to Hyperglycemic Ischemic Brain Injury and Tissue Plasminogen Activator.
    Hafez S; Abdelsaid M; Fagan SC; Ergul A
    Neurochem Res; 2018 Feb; 43(2):259-266. PubMed ID: 28975464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exacerbation of Thromboinflammation by Hyperglycemia Precipitates Cerebral Infarct Growth and Hemorrhagic Transformation.
    Desilles JP; Syvannarath V; Ollivier V; Journé C; Delbosc S; Ducroux C; Boisseau W; Louedec L; Di Meglio L; Loyau S; Jandrot-Perrus M; Potier L; Michel JB; Mazighi M; Ho-Tin-Noé B
    Stroke; 2017 Jul; 48(7):1932-1940. PubMed ID: 28526762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opening the window: Ischemic postconditioning reduces the hyperemic response of delayed tissue plasminogen activator and extends its therapeutic time window in an embolic stroke model.
    Esmaeeli-Nadimi A; Kennedy D; Allahtavakoli M
    Eur J Pharmacol; 2015 Oct; 764():55-62. PubMed ID: 26123846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YiQiFuMai Lyophilized Injection ameliorates tPA-induced hemorrhagic transformation by inhibiting cytoskeletal rearrangement associated with ROCK1 and NF-κB signaling pathways.
    Pan XW; Wang MJ; Gong SS; Sun MH; Wang Y; Zhang YY; Li F; Yu BY; Kou JP
    J Ethnopharmacol; 2020 Nov; 262():113161. PubMed ID: 32730882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.